30 Mar 2017 | 12:22 PM
 

Lupin Ltd. Share Price Live (BSE)
0

BSE Code: 500257 | NSE Symbol: LUPIN
1,456.10
3.15
(0.22 %)
30 Mar 2017 | 12:15 PM
Change company
  • Open (Rs)
    1,451.60
  • Prev. close (Rs.)
    1,452.95
  • High (Rs.)
    1,456.95
  • Low (Rs.)
    1,448.00
  • 52W H (Rs.)
    1,750.00
  • 52W L (Rs.)
    1,383.50
  • Volume (Rs.)
    16050
  • MCap (Rs in Cr.)
    65,733.60

Stock Market News

Lupin Ltd. Stock News

Company Name
From Date
To Date
  Lupin Ltd. | 24 Mar 2017 | 09:27:00
Pharma major Lupin Limited has said that it has received final approval for its Tobramycin Inhalation Solution USP 300 mg/5 ml from the United States Food and Drug Administration (FDA) to market a generic version of Novartis Pharmaceuticals Corporation&rsq...
  Lupin Ltd. | 16 Mar 2017 | 16:37:00
Pharma major Lupin said that it has launched generic Minastrin® 24 Fe chewable tablets in the US having received an approval from United States Food and Drug Administration (USFDA) earlier...
  Lupin Ltd. | 09 Mar 2017 | 12:09:00
Pharma major Lupin Ltd on Thursday said it has launched the pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.


“Lupin launches Hydrocodone Bitartrate and Acetaminophen tablets USP 5 mg/300 mg 7...

  Lupin Ltd. | 07 Mar 2017 | 14:48:00
Pharma major Lupin Ltd on Tuesday said that it has launched the generic Paxil CR (Paroxetin) extended release tablets USP 12.5 mg 25 mg and 37.5 mg used for the treatment of major depressive order in the US market...
  Lupin Ltd. | 03 Mar 2017 | 16:24:00
Pharma major Lupin Ltd on Friday said it has received final approval for its sodium sulfate potassium sulfate and magnesium sulfate oral solution 17.5 g/3.13 g/1...
  Lupin Ltd. | 02 Mar 2017 | 16:00:00
Drug major Lupin has launched generic version of Wyeth's Pristiq tablets an anti-depressant drug in the American market...
  Lupin Ltd. | 28 Feb 2017 | 12:58:00
Pharma major Lupin Ltd said that it has received final approval from the USFDA to market a pain relief drug.


“Lupin received final approval for its Oxycodone and Acetaminophen Tablets USP 2.5 mg/325 mg 5 mg/325 mg 7...

  Lupin Ltd. | 28 Feb 2017 | 11:41:00
Drug maker. Lupin Ltd said that it has received final approval from the USFDA to market sodium sulfate potassium sulfate magnesium sulfate oral solution used in treatment of a form of cancer...

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Lupin Ltd. that will help you decide whether to buy, sell or hold Lupin Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Lupin Ltd.